Our mutation analysis revealed many features differentially enriched between the DTBC vs LumA tumors, with many implicated in BC previously, such as TP53 mutations, 5q deletion, 1q21 amplification, etc. Our study demonstrated that many of these features are shared among DTBC tumors. This evidence concerns the gene TP53 and breast cancer.